CCML

The semiconductor sector faced unprecedented transformation in September as Skyworks Solutions moved closer to finalizing its $22 billion acquisition of Qorvo (QRVO.US). With 91.68% of 2029-dated notes tendered, the deal's completion now hinges on Chinese regulatory approval. Simultaneously, Qorvo achieved a 400% power density leap in DARPA-funded GaN transistor development, reinforcing its strategic value.

Axcelis Technologies (ACLS.US) signaled confidence in semiconductor equipment demand through its participation in September's ICSCRM conference, where CEO Russell Low highlighted the company's pivotal role in silicon carbide manufacturing. The firm's Q2 revenue grew 8.15% sequentially, contrasting with broader market volatility.

Leadership turbulence emerged as a sector-wide theme. Tungray Technologies (TRSG.US) saw abrupt CEO transition when Wanjun Yao resigned, succeeded by longtime executive Liling Du. FinVolution Group (FINV.US) faced intensified pressure as Chinese consumer credit platforms grappled with regulatory headwinds and Weiss Ratings' sell recommendation.

Biotech firms navigated critical junctures: Aclaris Therapeutics (ACRS.US) maintained 'strong buy' ratings despite revenue declines, while Quantum-Si (QSI.US) pushed back product launches but showcased promising proteomics data at World HUPO 2026. MoonLake Immunotherapeutics (MLTX.US) remained dependent on Phase III trial outcomes to justify its billion-dollar valuation.

AmpliTech Group (AMPG.US) reported 50.86% sequential revenue growth but warned of near-term margin pressures from 5G infrastructure investments. CCML.US and similar ETF vehicles remained largely dormant amid the sector's realignment.